Kristian Reich

Company: MoonLake Immunotherapeutics

Job title: Founder & Chief Scientific Officer

Seminars:

Advancing Drug Development in Hidradenitis Suppurativa (HS) Through Translational Research & Biomarker Science: Providing New Clarity to Disease State & Treatment Response 12:00 pm

HS is a highly inflammatory condition characterized by deep dermal lesions — notably draining tunnels — that are the predominant sources of inflammation, with disease activity also reflected in elevated levels of systemic inflammation Many aspects of HS pathogenesis remain poorly understood, posing a barrier to drug development (as reflected in numerous unsuccessful clinical trials…Read more

day: Day Two Discovery Track AM